Cigna (0A77) Share Forecast & Price Target

1 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

0A77 Analyst Ratings

Strong Buy

13 Buy

4 Hold

0 Sell

Based on 17 analysts giving stock ratings to

Cigna

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

0A77 Stock 12 Month Forecast

Average Price Target

$342.63

▲(17.40% Upside)

Based on 17 Wall Street analysts offering 12 month price targets for Cigna in the last 3 months. The average price target is $342.63 with a high forecast of $381.00 and a low forecast of $305.00. The average price target represents a 17.40% change from the last price of $291.84.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"239":"$239","382":"$382","274.75":"$274.8","310.5":"$310.5","346.25":"$346.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":381,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$381.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":342.625,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$342.63</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":305,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$305.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[239,274.75,310.5,346.25,382],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,282.66,290.2246153846154,297.7892307692308,305.3538461538462,312.91846153846154,320.48307692307696,328.04769230769233,335.6123076923077,343.1769230769231,350.7415384615385,358.30615384615385,365.87076923076927,373.43538461538463,{"y":381,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,282.66,287.27269230769235,291.8853846153846,296.49807692307695,301.1107692307692,305.72346153846155,310.3361538461539,314.94884615384615,319.5615384615385,324.1742307692308,328.7869230769231,333.3996153846154,338.0123076923077,{"y":342.625,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,282.66,284.3784615384616,286.0969230769231,287.81538461538463,289.5338461538462,291.2523076923077,292.97076923076924,294.6892307692308,296.40769230769234,298.12615384615384,299.8446153846154,301.56307692307695,303.28153846153845,{"y":305,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":252.614,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":295.134,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":287.592,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":240.144,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":272.239,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":273.306,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":268.184,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":284.954,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":266.694,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":281.285,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":272.888,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":275.1,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":282.66,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$381.00

Average Price Target$342.63

Lowest Price Target$305.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Lance Wilkes

Bernstein

$381

Buy

30.55%

Upside

Assigned

08/28/26

Bernstein Gives a Buy Rating to Cigna (CI)

Jessica Tassan

Piper Sandler

$346

Buy

18.56%

Upside

Reiterated

08/26/26

Piper Sandler Remains a Buy on Cigna (CI)

David Windley

Jefferies

$336→$307

Hold

5.19%

Upside

Downgraded

08/03/26

Cigna downgraded to Hold from Buy at JefferiesCigna downgraded to Hold from Buy at Jefferies

Parker Snure

Raymond James

$350→$320

Buy

9.65%

Upside

Reiterated

08/03/26

Cigna downgraded to Outperform from Strong Buy at Raymond JamesCigna downgraded to Outperform from Strong Buy at Raymond James

Scott Fidel

Goldman Sachs

$340→$352

Buy

20.61%

Upside

Reiterated

08/02/26

Analysts Conflicted on These Healthcare Names: AbbVie (NYSE: ABBV), HealthStream (NASDAQ: HSTM) and Cigna (NYSE: CI)

Unknown Analyst

Oppenheimer

Not Ranked

Oppenheimer

$365

Buy

25.07%

Upside

Reiterated

07/31/26

Oppenheimer Keeps Their Buy Rating on Cigna (CI)

Erin Wright

Morgan Stanley

$361

Buy

23.70%

Upside

Reiterated

07/31/26

Morgan Stanley Sticks to Their Buy Rating for Cigna (CI)

David S Macdonald

Truist Financial

$350

Buy

19.93%

Upside

Reiterated

07/31/26

Analysts' Top Healthcare Picks: Merit Medical Systems (MMSI), Dexcom (DXCM)

George Hill

Deutsche Bank

$302→$305

Hold

4.51%

Upside

Reiterated

07/31/26

Cigna price target raised to $305 from $302 at Deutsche BankCigna price target raised to $305 from $302 at Deutsche Bank

Stephen Baxter

Wells Fargo

$305→$307

Hold

5.19%

Upside

Assigned

07/31/26

Stephen Baxter Maintains Hold on Cigna, Nudges Price Target Up to $307 Amid Strong Healthcare Performance but PBM Uncertainties

Michael Ha

Robert W. Baird

$337→$362

Buy

24.04%

Upside

Reiterated

07/31/26

Cigna price target raised to $362 from $337 at BairdCigna price target raised to $362 from $337 at Baird

Andrew Mok CFA

Barclays

$304→$310

Hold

6.22%

Upside

Reiterated

07/31/26

Barclays Sticks to Its Hold Rating for Cigna (CI)

Lisa Gill

J.P. Morgan

―

Buy

―

Reiterated

07/30/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Ben Hendrix

RBC Capital

$337

Buy

15.47%

Upside

Reiterated

07/30/26

RBC Capital Sticks to Its Buy Rating for Cigna (CI)

Jason Cassorla

Guggenheim

$338→$361

Buy

23.70%

Upside

Reiterated

07/30/26

Cigna price target raised to $361 from $338 at GuggenheimCigna price target raised to $361 from $338 at Guggenheim

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Lance Wilkes

Bernstein

$381

Buy

30.55%

Upside

Assigned

08/28/26

Bernstein Gives a Buy Rating to Cigna (CI)

Jessica Tassan

Piper Sandler

$346

Buy

18.56%

Upside

Reiterated

08/26/26

Piper Sandler Remains a Buy on Cigna (CI)

David Windley

Jefferies

$336→$307

Hold

5.19%

Upside

Downgraded

08/03/26

Cigna downgraded to Hold from Buy at JefferiesCigna downgraded to Hold from Buy at Jefferies

Parker Snure

Raymond James

$350→$320

Buy

9.65%

Upside

Reiterated

08/03/26

Cigna downgraded to Outperform from Strong Buy at Raymond JamesCigna downgraded to Outperform from Strong Buy at Raymond James

Scott Fidel

Goldman Sachs

$340→$352

Buy

20.61%

Upside

Reiterated

08/02/26

Analysts Conflicted on These Healthcare Names: AbbVie (NYSE: ABBV), HealthStream (NASDAQ: HSTM) and Cigna (NYSE: CI)

Unknown Analyst

Oppenheimer

Not Ranked

Oppenheimer

$365

Buy

25.07%

Upside

Reiterated

07/31/26

Oppenheimer Keeps Their Buy Rating on Cigna (CI)

Erin Wright

Morgan Stanley

$361

Buy

23.70%

Upside

Reiterated

07/31/26

Morgan Stanley Sticks to Their Buy Rating for Cigna (CI)

David S Macdonald

Truist Financial

$350

Buy

19.93%

Upside

Reiterated

07/31/26

Analysts' Top Healthcare Picks: Merit Medical Systems (MMSI), Dexcom (DXCM)

George Hill

Deutsche Bank

$302→$305

Hold

4.51%

Upside

Reiterated

07/31/26

Cigna price target raised to $305 from $302 at Deutsche BankCigna price target raised to $305 from $302 at Deutsche Bank

Stephen Baxter

Wells Fargo

$305→$307

Hold

5.19%

Upside

Assigned

07/31/26

Stephen Baxter Maintains Hold on Cigna, Nudges Price Target Up to $307 Amid Strong Healthcare Performance but PBM Uncertainties

Michael Ha

Robert W. Baird

$337→$362

Buy

24.04%

Upside

Reiterated

07/31/26

Cigna price target raised to $362 from $337 at BairdCigna price target raised to $362 from $337 at Baird

Andrew Mok CFA

Barclays

$304→$310

Hold

6.22%

Upside

Reiterated

07/31/26

Barclays Sticks to Its Hold Rating for Cigna (CI)

Lisa Gill

J.P. Morgan

―

Buy

―

Reiterated

07/30/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Ben Hendrix

RBC Capital

$337

Buy

15.47%

Upside

Reiterated

07/30/26

RBC Capital Sticks to Its Buy Rating for Cigna (CI)

Jason Cassorla

Guggenheim

$338→$361

Buy

23.70%

Upside

Reiterated

07/30/26

Cigna price target raised to $361 from $338 at GuggenheimCigna price target raised to $361 from $338 at Guggenheim

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

ODTXOdyssey Therapeutics, Inc.

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

GPCRStructure Therapeutics, Inc. Sponsored ADR

AMLXAmylyx Pharmaceuticals Inc

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cigna

3 Months

Ann HynesMizuho Securities

Success Rate

17/28 ratings generated profit

Average Return

+4.32%

Copying Ann Hynes's trades and holding each position for 3 Months would result in 60.71% of your transactions generating a profit, with an average return of +4.32% per trade.

1 Year

Scott FidelGoldman Sachs

Success Rate

22/32 ratings generated profit

Average Return

+15.84%

Copying Scott Fidel's trades and holding each position for 1 Year would result in 68.75% of your transactions generating a profit, with an average return of +15.84% per trade.

2 Years

Scott FidelGoldman Sachs

Success Rate

26/32 ratings generated profit

Average Return

+23.13%

Copying Scott Fidel's trades and holding each position for 2 Years would result in 81.25% of your transactions generating a profit, with an average return of +23.13% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0A77 Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0A77 has received 21 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. 0A77 average Analyst price target in the past 3 months is 342.63.

Each month's total comprises the sum of three months' worth of ratings.

0A77 Financial Forecast

0A77 Earnings Forecast

Next quarter’s earnings estimate for 0A77 is $7.51 with a range of $7.42 to $7.80. The previous quarter’s EPS was $7.78. 0A77 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0A77 has Performed in-line its overall industry.

0A77 Sales Forecast

Next quarter’s sales forecast for 0A77 is $72.65B with a range of $70.51B to $74.28B. The previous quarter’s sales results were $71.60B. 0A77 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0A77 has Performed in-line its overall industry.

0A77 Stock Forecast FAQ

What is GB:0A77’s average 12-month price target, according to analysts?

Based on analyst ratings, Cigna Corp’s 12-month average price target is 342.63.

What is GB:0A77’s upside potential, based on the analysts’ average price target?

Cigna Corp has 17.40% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Cigna Corp a Buy, Sell or Hold?

Cigna Corp has a consensus rating of Strong Buy, which is based on 13 buy ratings, 4 hold ratings and 0 sell ratings.

What is Cigna Corp’s share price target?

The average share price target for Cigna Corp is 342.63. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $381.00 ,and the lowest forecast is $305.00. The average share price target represents 17.40% Increase from the current price of $291.84.

What do analysts say about Cigna Corp?

Cigna Corp’s analyst rating consensus is a Strong Buy. This is based on the ratings of 17 Wall Streets Analysts.

How can I buy shares of Cigna Corp?

To buy shares of GB:0A77, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Cigna (0A77) Share Forecast & Price Target

0A77 Analyst Ratings

0A77 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Cigna

0A77 Analyst Recommendation Trends

0A77 Financial Forecast

0A77 Earnings Forecast

0A77 Sales Forecast

0A77 Stock Forecast FAQ

Detailed List of Analyst Forecasts